期刊文献+

甘精胰岛素治疗围手术期糖尿病患者高血糖 被引量:9

Treatment of hyperglycemia levels during perioperative period using insulin glargine
下载PDF
导出
摘要 目的观察甘精胰岛素对围手术期糖尿病患者高血糖治疗的有效性、安全性和患者的依从性。方法选择40例接受外科及妇科手术的糖尿病患者,于围手术期禁食水时,应用甘精胰岛素注射液(来得时)皮下注射,观察用药前后血糖控制水平、低血糖发生率和患者依从性。结果应用甘精胰岛素后患者血糖较治疗前显著降低(P<0.05),发生1次低血糖事件。结论对于围手术期禁食水的糖尿病患者,甘精胰岛素是一种有效、安全且患者易于接受的药物。 Objective To observe the effect, security and survivability of insulin glargine on hyperglycemia levels during perioperative period. Methods 40 patients with diabetes who prepared to accept surgical and gynecological surgery were treated with insulin glargine(Latus) in the perioperative application of water fasting. The blood glucose levels,incidence of hypoglycemia and survivability were observed. Results There was a significant decrease of blood glucose levels after using insulin glargine(P〈0.05), one low blood glucose event occurred, Conclusion Insulin glargine is an effective, safe and digestible drug for the patients with diabetes who prepare to accept surgery.
出处 《实用药物与临床》 CAS 2009年第2期91-92,共2页 Practical Pharmacy and Clinical Remedies
关键词 甘精胰岛素 围手术期 高血糖 Insulin glargine Perioperative period Hyperglycemia
  • 相关文献

参考文献6

  • 1Swati Datta, Arshia Qaadir, Griselda Villanueva, et al. Oncedaily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure : a randomized clinical trial[ J ]. Endocrine Practice,2007, 13(3) :225-230.
  • 2苏秀海,田风胜,卢洁荷,王元松,李文东,王晓蕴,李永星,张洪运.胰岛素泵在糖尿病患者围手术期的应用研究[J].实用糖尿病杂志,2005,13(1):35-37. 被引量:22
  • 3Wang F, Carabino JM, Vergara CM. Insulin glargine: a systematic review of a long-acting insulin analogue[ J]. Clin Ther, 2003,25 (6) :1541-1576.
  • 4Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine[ J]. Diabetes Care,2005,28(6) :1282-1289.
  • 5Guthrie RA,Hinnen D,Childs BP. Glargine:A New Basal Insulin,A New Opportunity [ J]. Diabetes Spectr, 2001,14 ( 3 ) : 120-121.
  • 6Rosenstock J, Dailey G, Massi-Benedetti M, et al, Reduced hypoglycemia risk with insulin glargine:a meta-analysis comparing insulin gulargine with human NPH insulin in type 2 diabetes[ J]. Diabetes Care,2005,28(4) :950-955.

二级参考文献3

  • 1Unger J. Fredrickson. L. A. primer on imensive diabetes management and insulin pump therapy Primary Care Rop 1997; 3( 1 ): 9 -18.
  • 2Sanfield JA, Hegstad M. Hanna Rs Protocol for outpatient screening and initiating of continuous subcutaneous insulin infusion therapy impact on cost and quality. Diabetes Educa 2002;28(4): 599- 607.
  • 3Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglycemia, better metabolic control, and improve quality of life in Type ldiabetes Mellitus with continuous subcutaneous insulin infusion(CSⅡ)therapy;an observational study of 100 consecutive patients followed for amean of 2 years. Diabetes Med 2002; 19 (9): 746 - 751.

共引文献21

同被引文献82

引证文献9

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部